Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
European Heart Journal. Cardiovascular Imaging
|
October 19, 2017
Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging
Maurizio Galderisi, Bernard Cosyns, Thor Edvardsen, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
April 9, 2019
The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry
Gilbert Habib, Patrizio Lancellotti, Paola-Anna Erba, et al.
Current Oncology (Toronto, Ont.)
|
July 25, 2025
Impact of Oncological Treatment on Quality of Life in Patients with Head and Neck Malignancies: A Systematic Literature Review (2020-2025)
Raluca Grigore, Paula Luiza Bejenaru, Gloria Simona Berteșteanu, et al.
Haematologica
|
January 26, 2023
Venetoclax and dinaciclib elicit synergistic preclinical efficacy against hypodiploid acute lymphoblastic leukemia
Holly Pariury, Joshua Fandel, Stefanie Bachl, et al.
Cell Reports. Medicine
|
November 22, 2023
Allosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AML
Bogdan Popescu, Carlos Stahlhut, Theodore C Tarver, et al.
Blood Advances
|
January 28, 2020
Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia
Haydar Çelik, Katherine E Lindblad, Bogdan Popescu, et al.
Blood
|
October 27, 2025
Multiselective RAS(ON) inhibition targets oncogenic RAS and overcomes RAS-mediated resistance to FLT3i and BCL2i in AML
Bogdan Popescu, Matthew F Jones, Madison Piao, et al.
Blood
|
June 1, 2026
Dynamic genetic and nongenetic RAS pathway activation drives resistance to FLT3 and BCL2 inhibitor therapy
Vanessa E Kennedy, Cheryl A C Peretz, Anushka Walia, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
European Heart Journal. Cardiovascular Imaging
|
October 19, 2017
Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging
Maurizio Galderisi, Bernard Cosyns, Thor Edvardsen, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
April 9, 2019
The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry
Gilbert Habib, Patrizio Lancellotti, Paola-Anna Erba, et al.
Current Oncology (Toronto, Ont.)
|
July 25, 2025
Impact of Oncological Treatment on Quality of Life in Patients with Head and Neck Malignancies: A Systematic Literature Review (2020-2025)
Raluca Grigore, Paula Luiza Bejenaru, Gloria Simona Berteșteanu, et al.
Haematologica
|
January 26, 2023
Venetoclax and dinaciclib elicit synergistic preclinical efficacy against hypodiploid acute lymphoblastic leukemia
Holly Pariury, Joshua Fandel, Stefanie Bachl, et al.
Cell Reports. Medicine
|
November 22, 2023
Allosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AML
Bogdan Popescu, Carlos Stahlhut, Theodore C Tarver, et al.
Blood Advances
|
January 28, 2020
Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia
Haydar Çelik, Katherine E Lindblad, Bogdan Popescu, et al.
Blood
|
October 27, 2025
Multiselective RAS(ON) inhibition targets oncogenic RAS and overcomes RAS-mediated resistance to FLT3i and BCL2i in AML
Bogdan Popescu, Matthew F Jones, Madison Piao, et al.
Blood
|
June 1, 2026
Dynamic genetic and nongenetic RAS pathway activation drives resistance to FLT3 and BCL2 inhibitor therapy
Vanessa E Kennedy, Cheryl A C Peretz, Anushka Walia, et al.
Page
of 6